Novo Nordisk (alt)
Novo Nordisk (alt)
Aktie · DK0060534915 · A1XA8R (LSSI)
Übersicht Finanzkennzahlen
59,25 EUR
1,80 % 1,05 EUR
Lang & Schwarz · Aktuelle Kurse und Charts bei MoneyPeak
30.06.2025 19:50

Aktuelle Kurse von Novo Nordisk (alt)

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XETR: XETRA
XETRA
NOVC.DE
EUR
14.11.2023 15:35
91,40 EUR
0,00 EUR

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
1,75 % -1,93 % - - -35,17 % -35,17 % 103,83 %

Firmenprofil zu Novo Nordisk (alt) Aktie

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Investierte Fonds

Folgende Fonds haben in investiert: Novo Nordisk (alt) investiert:

Fonds
iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc)
Vol. in Mio
4.437,90
Anteil (%)
10,16 %
Fonds
iShares Edge MSCI Europe Quality Factor UCITS ETF EUR (Dist)
Vol. in Mio
250,88
Anteil (%)
5,84 %
Fonds
iShares MSCI Europe SRI UCITS ETF USD (Acc)
Vol. in Mio
1.972,07
Anteil (%)
4,23 %
Fonds
iShares MSCI Europe SRI UCITS ETF EUR (Dist)
Vol. in Mio
29.740,69
Anteil (%)
4,23 %
Fonds
iShares MSCI Europe SRI UCITS ETF EUR (Acc)
Vol. in Mio
156.684,12
Anteil (%)
4,23 %

Unternehmensdaten

Name Novo Nordisk (alt)
Firma Novo Nordisk A/S
Website https://www.novonordisk.com/
Heimatbörse LSSI Lang & Schwarz
WKN A1XA8R
ISIN DK0060534915
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Pharmaceuticals
CEO Mr. Lars Fruergaard Jorgensen
Marktkapitalisierung 407 Mrd.
Land Dänemark
Währung EUR
Mitarbeiter 59,3 T
Adresse Novo Alle, Bagsvaerd
IPO Datum 2001-06-07

Aktien-Splits

Datum Split
13.09.2023 2:1

Ticker Symbole

Name Symbol
XETRA NOVC.DE

Weitere Aktien

Investoren die Novo Nordisk (alt) die halten, haben auch folgende Aktien im Depot:
ALLIANZ AG
ALLIANZ AG Aktie
AMAZON.CO INC
AMAZON.CO INC Aktie
APPLE INC
APPLE INC Aktie
BERKSHIRE HATHAWAY INC - CLASS B
BERKSHIRE HATHAWAY INC - CLASS B Aktie
CORE LITHIUM LTD
CORE LITHIUM LTD Aktie
HSBC MSCI WORLD UCITS ETF
HSBC MSCI WORLD UCITS ETF ETF
Iveda Solutions, Inc. - Warrant
Iveda Solutions, Inc. - Warrant Aktie
JOHNSON & JOHNSON
JOHNSON & JOHNSON Aktie
META PLATFORMS INC
META PLATFORMS INC Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
Novo Nordisk
Novo Nordisk Aktie
SACHSEN-ANH.LS21/26
SACHSEN-ANH.LS21/26 Anleihe
TESLA INC
TESLA INC Aktie
UNILEVER PLC
UNILEVER PLC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025